CNTX — CONTEXT THERAPEUTICS INC

Ownership history in CAXTON CORP  ·  9 quarters on record

This page tracks every 13F SEC filing in which CAXTON CORP reported a position in CONTEXT THERAPEUTICS INC (CNTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.63% (2012 Q4)
Avg. % of fund
0.31%
First filed
2012 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 18,403 — 0% 0.63% $27K $1.47
2025 Q3 UNCHANGED 18,403 — 0% 0.08% $18K $0.97
2025 Q2 UNCHANGED 18,403 — 0% 0.12% $12K $0.65
2025 Q1 UNCHANGED 18,403 — 0% 0.22% $11.3M $0.61
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CNTX price (monthly, adj. close)

Other funds also holding CNTX

As of 2025 Q4 — sorted by position size

Avidity Partners Management LP 3Y 2.33% GREAT POINT PARTNERS LLC 3Y 7Y 2.23% MPM BioImpact LLC 3Y 1.8% Blue Owl Capital Holdings LP 3Y 0.82% Sio Capital Management, LLC 3Y 7Y 0.31% Deep Track Capital, LP 3Y 0.19% Velan Capital Investment Management LP 3Y 0.09% ADAR1 Capital Management, LLC 0.04% Blackstone Inc. 3Y 7Y 0.01% Clear Harbor Asset Management, LLC 3Y 7Y 0.01%
← Back to CAXTON CORP Holdings